Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

February 2012 - FRMC

Vemurafenib Accelerates Secondary Skin Cancer in Some Patients
02/22/2012

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
Although vemurafenib improves outcomes in patients with advanced melanoma that harbors a BRAF gene mutation, the drug also accelerates the development of squamous-cell carcinomas and keratoacanthomas in some patients. Results that show a skin...
Although vemurafenib improves outcomes in patients with advanced melanoma that harbors a BRAF gene mutation, the drug also accelerates the development of squamous-cell carcinomas and keratoacanthomas in some patients. Results that show a skin...
Although vemurafenib improves...
02/22/2012
First Report Managed Care
HPV Vaccination among Teens
02/22/2012

Kevin L. Carter

Kevin L. Carter
Human papillomavirus (HPV) is the most prevalent sexually transmitted infection (STI) in the United States. HPV has a prevalence of 29.5% in sexually experienced girls 14 to 19 years of age. Sequelae of HPV infection may include genital...
Human papillomavirus (HPV) is the most prevalent sexually transmitted infection (STI) in the United States. HPV has a prevalence of 29.5% in sexually experienced girls 14 to 19 years of age. Sequelae of HPV infection may include genital...
Human papillomavirus (HPV) is...
02/22/2012
First Report Managed Care
Treating Osteoporosis in Postmenopausal Women
02/22/2012

Tim Casey

Tim Casey
New Orleans—According to an analysis of clinical trials, bazedoxifene is effective as a second-line therapy for postmenopausal women who have osteoporosis, although the drug is not cost-effective compared with raloxifene. Bazedoxifene and...
New Orleans—According to an analysis of clinical trials, bazedoxifene is effective as a second-line therapy for postmenopausal women who have osteoporosis, although the drug is not cost-effective compared with raloxifene. Bazedoxifene and...
New Orleans—According to an...
02/22/2012
First Report Managed Care
Cost Comparison of Fulvestrant Regimens
02/22/2012

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
A study comparing the cost of fulvestrant found that 250 mg appears to be a cost-effective option in treating postmenopausal women with breast cancer.
A study comparing the cost of fulvestrant found that 250 mg appears to be a cost-effective option in treating postmenopausal women with breast cancer.
A study comparing the cost of...
02/22/2012
First Report Managed Care
Length of Hospital Stay Associated with Dabigatran and Warfarin
02/22/2012

Tim Casey

Tim Casey
New Orleans—A retrospective cohort study found that patients with atrial fibrillation (AF) who took dabigatran did not have a significant reduction in length of stay in a hospital compared with those who took warfarin. However, the authors...
New Orleans—A retrospective cohort study found that patients with atrial fibrillation (AF) who took dabigatran did not have a significant reduction in length of stay in a hospital compared with those who took warfarin. However, the authors...
New Orleans—A retrospective...
02/22/2012
First Report Managed Care
Cost-Effectiveness and Survival of HRPC Treatments
02/22/2012

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
To determine survival benefits for patients with hormone-refractory prostate cancer, researchers looked at treating HRPC with sipuleucel-T and docetaxel.
To determine survival benefits for patients with hormone-refractory prostate cancer, researchers looked at treating HRPC with sipuleucel-T and docetaxel.
To determine survival benefits...
02/22/2012
First Report Managed Care
TNF Antagonists and Cardiovascular Disease Risk
02/22/2012

Mary Beth Nierengarten

Mary Beth Nierengarten
Chicago—Data from a large epidemiologic study presented at the ACR meeting suggest a trend toward reduced cardiovascular disease (CVD) risk among patients with rheumatoid arthritis (RA) during the first 6 months of initiating treatment with...
Chicago—Data from a large epidemiologic study presented at the ACR meeting suggest a trend toward reduced cardiovascular disease (CVD) risk among patients with rheumatoid arthritis (RA) during the first 6 months of initiating treatment with...
Chicago—Data from a large...
02/22/2012
First Report Managed Care

Department

News Connection
Genital Herpes Vaccine Only Protects against One Strain of Virus
02/22/2012

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
A vaccine for genital herpes was effective in protecting some women from genital disease and infection from herpes simplex type 1 but not from type 2.
A vaccine for genital herpes was effective in protecting some women from genital disease and infection from herpes simplex type 1 but not from type 2.
A vaccine for genital herpes was...
02/22/2012
First Report Managed Care
Conference Insider
Serious Infections in Patients with Autoimmune Diseases
02/22/2012

Mary Beth Nierengarten

Mary Beth Nierengarten
Chicago—The risk of serious infection was not significantly increased in patients with autoimmune diseases initiating treatment with tumor necrosis factor (TNF) antagonists compared with those treated with nonbiologic disease regimens, even...
Chicago—The risk of serious infection was not significantly increased in patients with autoimmune diseases initiating treatment with tumor necrosis factor (TNF) antagonists compared with those treated with nonbiologic disease regimens, even...
Chicago—The risk of serious...
02/22/2012
First Report Managed Care
Conference Insider
Anti-TNF Therapy and Solid Cancer Risk
02/22/2012

Mary Beth Nierengarten

Mary Beth Nierengarten
Chicago—Patients treated with anti–tumor necrosis factor (TNF) therapy for rheumatoid arthritis (RA) are not at increased risk of solid cancers compared with patients receiving nonbiologic disease-modifying antirheumatic drugs (DMARDs),...
Chicago—Patients treated with anti–tumor necrosis factor (TNF) therapy for rheumatoid arthritis (RA) are not at increased risk of solid cancers compared with patients receiving nonbiologic disease-modifying antirheumatic drugs (DMARDs),...
Chicago—Patients treated with...
02/22/2012
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 2

Current Issue

June 2024
Volume 21
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Report: Cancer Will Kill 13.2 Million a Year by 2030
06/02/2010
06/02/2010
First Report Managed Care
Literature Review: Opioid-Induced Constipation
03/16/2015
These studies focus on the causes, consequences, and management of opioid-induced constipation.
These studies focus on the causes, consequences, and management of opioid-induced constipation.
These studies focus on the...
03/16/2015
First Report Managed Care
News
New Standardized Insurance Forms Could Make Buying Easier
08/23/2011
08/23/2011
First Report Managed Care
News
FDA Approves Denosumab for New Indication
12/10/2014
The FDA approved denosumab for the treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy.
The FDA approved denosumab for the treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy.
The FDA approved denosumab for...
12/10/2014
First Report Managed Care
News
CMS Announces Voluntary Bundled Payment Model
01/10/2018
The CMS recently announced the launch of a new voluntary bundled payment model that will cover multiple specialties and care services.
The CMS recently announced the launch of a new voluntary bundled payment model that will cover multiple specialties and care services.
The CMS recently announced the...
01/10/2018
First Report Managed Care

Video Insights

Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

February 2012 Volume 9 Issue 2

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement